Article Text

Download PDFPDF
A comparison between quick-release nicotine lozenges and Swedish-style snus for the acute management of craving
  1. Sean P Barrett,
  2. Erin Wagner
  1. Life Sciences Centre, Department of Psychology, Dalhousie University, Halifax, Nova Scotia, Canada
  1. Correspondence to Dr Sean P Barrett, Associate Professor, Life Sciences Centre, Department of Psychology, Dalhousie University, 1355 Oxford Street, Halifax, NS B3H 4J1, Canada; sean.barrett{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Swedish-style snus (SS) has been proposed as a smoking cessation aid.1 2 In Norway, SS use has been reported to be a common self-selected smoking cessation strategy,3 and it has been argued that the relatively low rates of smoking in Sweden may be in part attributable to SS use.1 4 However, because SS is not risk-free and its use may be associated with the development of dependence, its use for smoking cessation remains a subject of controversy.5 We recently reported that acute SS administration (8 mg of nicotine) significantly reduced craving relative to a nicotine/tobacco-free snus as well as to a 2 mg nicotine lozenge (NL).6 However, differences in …

View Full Text


  • Funding This work was supported by a seed grant awarded to SPB from The Canadian Action Network for the Advancement, Dissemination and Adoption of Practice-informed Tobacco Treatment (CAN-ADAPTT).

  • Competing interests None.

  • Ethics approval This study was conducted with the approval of the Capital District Health Authority, Halifax, Nova Scotia, Canada.

  • Provenance and peer review Not commissioned; externally peer reviewed.